Home › Brain Ischemia › NCT04998357
Autologous Mitochondrial Transplant for Cerebral Ischemia
Recruiting
Study Title: Autologous Mitochondrial Transplant for Cerebral Ischemia
Who can join
Ages 18 to 85 · All sexes
Full eligibility criteria
Inclusion Criteria: * Eligible for endovascular thrombectomy to treat acute large vessel occlusion * Eligible for angioplasty (microcatheter-based balloon/mechanical and chemical angioplasty) to treat acute cerebral vasospasm after aneurysmal subarachnoid hemorrhage * Subjects for whom there is likely to be enough time to obtain meaningful consent from patient or legally-authorized representative Exclusion Criteria: * Unable to receive a brain MRI scan * Known mitochondrial disease * Hemodynamically unstable patients in whom standard of care endovascular reperfusion treatment cannot safely be performed or completed
About the study
The investigators propose to infuse healthy autologous mitochondria into cerebral vessels supplying brain tissue experiencing ischemia in patients who undergo standard-of- care endovascular reperfusion therapy.
What is being tested
- Endovascular autologous mitochondrial transplantation (other)
Sponsor: University of Washington · Participants: 20 · Started: Apr 29, 2021
Contact the study team
- Study Coordinator · Phone: 206-897-5802
Official record on ClinicalTrials.gov — NCT04998357
Locations in the U.S.
| Washington | Harborview Medical Center, Seattle |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.